Impact of Different Diagnostic Criteria During Adrenal Vein Sampling on Reproducibility of Subtype Diagnosis in Patients With Primary Aldosteronism
- 1 March 2010
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 55 (3) , 667-673
- https://doi.org/10.1161/hypertensionaha.109.146613
Abstract
In patients with primary aldosteronism, adrenal vein sampling (AVS) is considered the only reliable technique to distinguish between unilateral and bilateral autonomous production of aldosterone, but agreement is lacking on the best criteria indicating successful cannulation and lateralization. The objective of this study was to assess the impact of differing criteria for the successful cannulation and lateralization on the reproducibility of subtype diagnosis. Sixty-two patients with confirmed primary aldosteronism underwent AVS on 2 separate occasions, because the first was unsatisfactory. We compared the different diagnoses of primary aldosteronism subtype reached using AVS data assessed by permissive (type 1), intermediate (type 2), and strict (type 3) criteria. Although 91.1% of all of the (both first and second) AVSs were "successful" by type 1 criteria (50.8% by type 2 and 33.9% by type 3), in only 35.3% of patients was the diagnosis concordant between the first and second AVS. Type 1 criteria also led to a higher rate of diagnosis of unilateral primary aldosteronism (67.3% of successful procedures) than type 2 (36.5%) or type 3 (26.2%). There was considerable disparity in the diagnosis reached using the 3 different criteria, with concordance in only 32.2%. Using either type 1 or 2 criteria, the minimal adrenal/peripheral vein cortisol ratio necessary to obtain the same diagnosis in the first and second AVS procedures was >/=2.75. In conclusion, permissive criteria for successful cannulation and lateralization on AVS achieve poor diagnostic reproducibility and should be avoided.Keywords
This publication has 29 references indexed in Scilit:
- Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2008
- Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary AldosteronismHypertension, 2007
- Prevalence and Characteristics of the Metabolic Syndrome in Primary AldosteronismJournal of Clinical Endocrinology & Metabolism, 2006
- Mineralocorticoid Receptor Blockade in the Protection of Target Organ DamageCardiovascular & Hematological Agents in Medicinal Chemistry, 2006
- Diagnosis of primary aldosteronism: from screening to subtype differentiationTrends in Endocrinology & Metabolism, 2005
- Evidence for an increased rate of cardiovascular events in patients with primary aldosteronismJournal of the American College of Cardiology, 2005
- Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five ContinentsJournal of Clinical Endocrinology & Metabolism, 2004
- High rate of detection of primary aldosteronism, including surgically treatable forms, after ???non-selective??? screening of hypertensive patientsJournal Of Hypertension, 2003
- HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSIONClinical and Experimental Pharmacology and Physiology, 1994
- Evolution of the Surgical Management of Primary AldosteronismAnnals of Surgery, 1980